C-AFHFCognito Therapeutics
gamma stimulation, audiovisual stimulation, neuroprotective therapy
trainingdevice hardware
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-AFHF
C-AFHFC-AFHFgamma stimulation, audiovisual stimulation, neuroprotective therapy
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Cognito Therapeutics gamma stimulation, audiovisual stimulation, neuroprotective therapy
Cognito Therapeutics is developing Spectris, an investigational non-invasive therapy platform designed to evoke specific brain wave activity. Its Spectris AD approach uses visual and auditory stimulation to evoke gamma wave activity in Alzheimer’s patients. The company reports OVERTURE feasibility study results showing slowing of cognitive and functional decline and preservation of brain volume among treated patients.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Cognito Therapeutics — Near-term readout · Bottom quartile. Derived deterministically from 5 extracted project(s). Most-advanced status: phase 3. Band: near_readout. Modifiers: +5 depth (2 programs at…
Source: Deterministic